Rituximab in refractory antiphospholipid syndrome

被引：0
|
作者：
Almomen, Abdul Kareem [1 ]
Cana, Sri-Halimah [2 ]
Hasanato, Rana
Abujamea, Abdullah [2 ]
机构：
[1] King Saud Univ, Coll Med, Ctr Excellence Thrombosis & Hemostasis, Riyadh 11586, Saudi Arabia
[2] King Saud Univ, King Khalid Univ Hosp, Riyadh 11461, Saudi Arabia
来源：
THROMBOSIS RESEARCH | 2012年 / 130卷
关键词：
D O I：
10.1016/j.thromres.2012.08.318
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S201 / S201
页数：1
相关论文
共 50 条
  • [41] Strategies for use of rituximab in refractory nephrotic syndrome
    Hayes, W.
    Christian, M.
    PEDIATRIC NEPHROLOGY, 2011, 26 (09) : 1654 - 1655
  • [42] Rituximab for refractory cases of childhood nephrotic syndrome
    Jameela A. Kari
    Salah M. El-Morshedy
    Sherif El-Desoky
    Hammad O. Alshaya
    Khawla A. Rahim
    Burhan M. Edrees
    Pediatric Nephrology, 2011, 26 : 733 - 737
  • [43] Refractory Morvan Syndrome Responding Dramatically to Rituximab
    Agha, M.
    Chedid, T.
    Sawaya, R.
    Makki, A.
    Beydoun, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 711 - 711
  • [44] Rituximab for Successful Management of Probable Pediatric Catastrophic Antiphospholipid Syndrome
    Rao, Amulya A. Nageswara
    Arteaga, Grace M.
    Reed, Ann M.
    Gloor, James M.
    Rodriguez, Vilmarie
    PEDIATRIC BLOOD & CANCER, 2009, 52 (04) : 536 - 538
  • [45] Rituximab in the management of pediatric catastrophic antiphospholipid syndrome: a case report
    Rao, Amulya A. Nageswara
    Rodriguez, Vilmarie
    Arteaga, Grace M.
    Reed, Ann M.
    Gloor, James M.
    HAEMOPHILIA, 2009, 15 (02) : 626 - 627
  • [46] Rituximab an adjunct therapy for antiphospholipid syndrome: a study of twelve cases
    Basavaraju, Renuka V.
    Schue, Jeremy
    Latinis, Kevin
    Stechschulte, Daniel J.
    ARTHRITIS AND RHEUMATISM, 2007, 56 (12): : 4240 - 4241
  • [47] The use of fondaparinux and rituximab for recurrent thrombotic events in antiphospholipid syndrome
    Sayar, Zara
    Burke, Shoshana
    Mittal, Prabal
    Cohen, Hannah
    LUPUS, 2022, 31 (12) : 1485 - 1490
  • [48] Rituximab reduces antiphospholipid antibody (APA) titers and improves hypercoagulability in patients with antiphospholipid syndrome (APS).
    Yamazaki, M
    Takami, A
    Asakura, H
    Nakao, S
    BLOOD, 2002, 100 (11) : 269A - 269A
  • [49] Rituximab use in the catastrophic antiphospholipid syndrome: Descriptive analysis of the CAPS registry patients receiving rituximab
    Berman, Horacio
    Rodriguez-Pinto, Ignasi
    Cervera, Ricard
    Morel, Nathalie
    Costedoat-Chalumeau, Nathalie
    Erkan, Doruk
    Shoenfeld, Yehuda
    Espinosa, Gerard
    AUTOIMMUNITY REVIEWS, 2013, 12 (11) : 1085 - 1090
  • [50] Are there additional options for the treatment of refractory obstetric antiphospholipid syndrome?
    Gomez-Puerta, J. A.
    Cervera, R.
    LUPUS, 2013, 22 (07) : 754 - 755
12345